| Home > Publications database > Scanned ion beam therapy for prostate carcinoma : Comparison of single plan treatment and daily plan-adapted treatment > print |
| 001 | 184394 | ||
| 005 | 20230504191718.0 | ||
| 024 | 7 | _ | |a 10.1007/s00066-015-0925-0 |2 doi |
| 024 | 7 | _ | |a pmid:26614393 |2 pmid |
| 024 | 7 | _ | |a 0039-2073 |2 ISSN |
| 024 | 7 | _ | |a 0179-7158 |2 ISSN |
| 024 | 7 | _ | |a 1439-099X |2 ISSN |
| 024 | 7 | _ | |a WOS:000371319700006 |2 WOS |
| 037 | _ | _ | |a GSI-2016-00124 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hild, Sebastian |0 P:(DE-Ds200)OR2921 |b 0 |
| 245 | _ | _ | |a Scanned ion beam therapy for prostate carcinoma : Comparison of single plan treatment and daily plan-adapted treatment |
| 260 | _ | _ | |a Heidelberg |c 2016 |b Springer29710 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1484146395_22241 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 315 - Imaging and radiooncology (POF3-315) |0 G:(DE-HGF)POF3-315 |c POF3-315 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-11-27 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Graeff, Christian |0 P:(DE-Ds200)OR5177 |b 1 |
| 700 | 1 | _ | |a Rucinski, Antoni |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Zink, Klemens |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Habl, Gregor |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Durante, Marco |0 P:(DE-Ds200)OR2413 |b 5 |
| 700 | 1 | _ | |a Herfarth, Klaus |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Bert, Christoph |0 P:(DE-Ds200)OR0109 |b 7 |e Corresponding author |
| 773 | 1 | 8 | |a 10.1007/s00066-015-0925-0 |b Springer Science and Business Media LLC |d 2015-11-27 |n 2 |p 118-126 |3 journal-article |2 Crossref |t Strahlentherapie und Onkologie |v 192 |y 2015 |x 0179-7158 |
| 773 | _ | _ | |a 10.1007/s00066-015-0925-0 |g Vol. 192, no. 2, p. 118 - 126 |0 PERI:(DE-600)2003907-4 |n 2 |p 118-126 |t Strahlentherapie und Onkologie |v 192 |y 2015 |x 0179-7158 |
| 787 | 0 | _ | |a Hild, Sebastian |0 GSI-2016-00157 |t Adaptive Treatment of prostate carcinoma in scanned ion beam therapy [cumulative PhD] |i IsMemberOf |d 2015 |
| 909 | C | O | |p VDB |o oai:repository.gsi.de:184394 |
| 910 | 1 | _ | |a GSI Helmholtzzentrum für Schwerionenforschung GmbH |0 I:(DE-Ds200)20121206GSI |k GSI |b 0 |6 P:(DE-Ds200)OR2921 |
| 910 | 1 | _ | |a GSI Helmholtzzentrum für Schwerionenforschung GmbH |0 I:(DE-Ds200)20121206GSI |k GSI |b 1 |6 P:(DE-Ds200)OR5177 |
| 910 | 1 | _ | |a GSI Helmholtzzentrum für Schwerionenforschung GmbH |0 I:(DE-Ds200)20121206GSI |k GSI |b 5 |6 P:(DE-Ds200)OR2413 |
| 910 | 1 | _ | |a GSI Helmholtzzentrum für Schwerionenforschung GmbH |0 I:(DE-Ds200)20121206GSI |k GSI |b 7 |6 P:(DE-Ds200)OR0109 |
| 913 | 2 | _ | |a DE-HGF |b POF III |l Forschungsbereich Gesundheit |1 G:(DE-HGF)POF3-300 |0 G:(DE-HGF)POF3-310 |2 G:(DE-HGF)POF3 |v Krebsforschung |9 G:(DE-HGF)POF3-315 |x 0 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-315 |2 G:(DE-HGF)POF3-300 |v Imaging and radiooncology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b STRAHLENTHER ONKOL : 2014 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Ds200)BIO-20160831OR354 |k BIO |l Biophysik |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Ds200)20110831OR021 |
| 980 | _ | _ | |a I:(DE-Ds200)BIO-20160831OR354 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1016/j.semradonc.2007.07.003 |9 -- missing cx lookup -- |1 M Herk van |p 258 - |2 Crossref |u van Herk M (2007) Different styles of image-guided radiotherapy. Semin Radiat Oncol 17:258–267 |t Semin Radiat Oncol |v 17 |y 2007 |
| 999 | C | 5 | |a 10.1186/1748-717X-2-24 |9 -- missing cx lookup -- |1 C Bert |p 24 - |2 Crossref |u Bert C, Rietzel E (2007) 4D treatment planning for scanned ion beams. Radiat Oncol 2:24 |t Radiat Oncol |v 2 |y 2007 |
| 999 | C | 5 | |a 10.1001/jama.294.10.1233 |9 -- missing cx lookup -- |1 AL Zietman |p 1233 - |2 Crossref |u Zietman AL, DeSilvio ML, Slater JD et al (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294:1233–1239 |t JAMA |v 294 |y 2005 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2004.07.709 |9 -- missing cx lookup -- |1 M Ghilezan |p 1602 - |2 Crossref |u Ghilezan M, Yan D, Liang J et al (2004) Online image-guided intensity-modulated radiotherapy for prostate cancer: how much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery. Int J Radiat Oncol Biol Phys 60:1602–1610 |t Int J Radiat Oncol Biol Phys |v 60 |y 2004 |
| 999 | C | 5 | |a 10.1093/jrr/rru080 |9 -- missing cx lookup -- |1 M Someya |p 122 - |2 Crossref |u Someya M, Hori M, Tateoka K et al (2015) Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer. J Radiat Res 56:122–127 |t J Radiat Res |v 56 |y 2015 |
| 999 | C | 5 | |a 10.1186/1471-2407-14-202 |9 -- missing cx lookup -- |1 G Habl |p 202 - |2 Crossref |u Habl G, Hatiboglu G, Edler L et al (2014) Ion Prostate Irradiation (IPI)—a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique. BMC Cancer 14:202 |t BMC Cancer |v 14 |y 2014 |
| 999 | C | 5 | |a 10.1111/iju.12640 |9 -- missing cx lookup -- |1 Y Shioyama |p 33 - |2 Crossref |u Shioyama Y, Tsuji H, Suefuji H et al (2015) Particle radiotherapy for prostate cancer. Int J Urol 22:33–39 |t Int J Urol |v 22 |y 2015 |
| 999 | C | 5 | |a 10.3109/0284186X.2011.584558 |9 -- missing cx lookup -- |1 AV Nikoghosyan |p 784 - |2 Crossref |u Nikoghosyan AV, Schulz-Ertner D, Herfarth K et al (2011) Acute toxicity of combined photon IMRT and carbon ion boost for intermediate-risk prostate cancer—acute toxicity of 12C for PC. Acta Oncol 50:784–790 |t Acta Oncol |v 50 |y 2011 |
| 999 | C | 5 | |a 10.1186/s13014-015-0348-1 |9 -- missing cx lookup -- |1 A Rucinski |p 348 - |2 Crossref |u Rucinski A, Brons S, Richter D et al (2015) Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel. Radiat Oncol 10:348 |t Radiat Oncol |v 10 |y 2015 |
| 999 | C | 5 | |a 10.1103/RevModPhys.82.383 |9 -- missing cx lookup -- |1 D Schardt |p 383 - |2 Crossref |u Schardt D, Elsässer T, Schulz-Ertner D (2010) Heavy-ion tumor therapy: physical and radiobiological benefits. Rev Mod Phys 82:383 |t Rev Mod Phys |v 82 |y 2010 |
| 999 | C | 5 | |a 10.1016/S0360-3016(03)00132-9 |9 -- missing cx lookup -- |1 JF Fowler |p 1093 - |2 Crossref |u Fowler JF, Ritter MA, Chappell RJ et al (2003) What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56:1093–1104 |t Int J Radiat Oncol Biol Phys |v 56 |y 2003 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2003.10.017 |9 -- missing cx lookup -- |1 M Ghilezan |p 406 - |2 Crossref |u Ghilezan M, Jaffray D, Siewerdsen JH et al (2005) Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol 62:406–417 |t Int J Radiat Oncol |v 62 |y 2005 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2007.11.054 |9 -- missing cx lookup -- |1 KM Langen |p 1084 - |2 Crossref |u Langen KM, Willoughby TR, Meeks SL et al (2008) Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 71:1084–1090 |t Int J Radiat Oncol Biol Phys |v 71 |y 2008 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2010.05.008 |9 -- missing cx lookup -- |1 C Peng |p 909 - |2 Crossref |u Peng C, Ahunbay E, Chen G et al (2011) Characterizing interfraction variations and their dosimetric effects in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 79:909–914 |t Int J Radiat Oncol Biol Phys |v 79 |y 2011 |
| 999 | C | 5 | |a 10.1016/S0360-3016(00)00608-8 |9 -- missing cx lookup -- |1 D Yan |p 289 - |2 Crossref |u Yan D, Lockman D, Brabbins D et al (2000) An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys 48:289–302 |t Int J Radiat Oncol Biol Phys |v 48 |y 2000 |
| 999 | C | 5 | |a 10.1118/1.4749964 |9 -- missing cx lookup -- |1 C Graeff |p 6004 - |2 Crossref |u Graeff C, Durante M, Bert C (2012) Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes. Med Phys 39:6004–6013 |t Med Phys |v 39 |y 2012 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2009.10.013 |9 -- missing cx lookup -- |1 EE Ahunbay |p 1561 - |2 Crossref |u Ahunbay EE, Peng C, Holmes S et al (2010) Online adaptive replanning method for prostate radiotherapy. Int J Radiat Oncol Biol Phys 77:1561–1572 |t Int J Radiat Oncol Biol Phys |v 77 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2011.04.043 |9 -- missing cx lookup -- |1 S Shimizu |p e393 - |2 Crossref |u Shimizu S, Osaka Y, Shinohara N et al (2011) Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys 81:e393–e399 |t Int J Radiat Oncol Biol Phys |v 81 |y 2011 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2011.06.1974 |9 -- missing cx lookup -- |1 S Tang |p 408 - |2 Crossref |u Tang S, Both S, Bentefour H et al (2012) Improvement of prostate treatment by anterior proton fields. Int J Radiat Oncol Biol Phys 83:408–418 |t Int J Radiat Oncol Biol Phys |v 83 |y 2012 |
| 999 | C | 5 | |a 10.1118/1.4881522 |9 -- missing cx lookup -- |1 S Hild |p 071703 - |2 Crossref |u Hild S, Graeff C, Trautmann J et al (2014) Fast optimization and dose calculation in scanned ion beam therapy. Med Phys 41:071703 |t Med Phys |v 41 |y 2014 |
| 999 | C | 5 | |a 10.1259/bjr/88849490 |9 -- missing cx lookup -- |1 C Thieke |p S79 - |2 Crossref |u Thieke C, Malsch U, Schlegel W et al (2006) Kilovoltage CT using a linac-CT scanner combination. Br J Radiol 79:S79–S86 |t Br J Radiol |v 79 |y 2006 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2006.06.044 |9 -- missing cx lookup -- |1 JC O’Daniel |p 883 - |2 Crossref |u O’Daniel JC, Dong L, Zhang L et al (2006) Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 66:883–891 |t Int J Radiat Oncol Biol Phys |v 66 |y 2006 |
| 999 | C | 5 | |a 10.1016/S0360-3016(00)00518-6 |9 -- missing cx lookup -- |1 Mv Herk |p 1121 - |2 Crossref |u Herk Mv, Remeijer P, Rasch C et al (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47:1121–1135 |t Int J Radiat Oncol Biol Phys |v 47 |y 2000 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2008.03.045 |9 -- missing cx lookup -- |1 JR Wong |p 1396 - |2 Crossref |u Wong JR, Gao Z, Uematsu M et al (2008) Interfractional prostate shifts: review of 1870 computed tomography (CT) scans obtained during image-guided radiotherapy using CT-on-rails for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 72:1396–1401 |t Int J Radiat Oncol Biol Phys |v 72 |y 2008 |
| 999 | C | 5 | |a 10.1088/0031-9155/45/11/314 |9 -- missing cx lookup -- |1 M Krämer |p 3319 - |2 Crossref |u Krämer M, Scholz M (2000) Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose. Phys Med Biol 45:3319–3330 |t Phys Med Biol |v 45 |y 2000 |
| 999 | C | 5 | |a 10.1118/1.4800802 |9 -- missing cx lookup -- |1 D Richter |p 051722 - |2 Crossref |u Richter D, Schwarzkopf A, Trautmann J et al (2013) Upgrade and benchmarking of a 4D treatment planning system for scanned ion beam therapy. Med Phys 40:051722 |t Med Phys |v 40 |y 2013 |
| 999 | C | 5 | |a 10.1007/s004110050055 |9 -- missing cx lookup -- |1 M Scholz |p 59 - |2 Crossref |u Scholz M, Kellerer AM, Kraft-Weyrather W et al (1997) Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys 36:59–66 |t Radiat Environ Biophys |v 36 |y 1997 |
| 999 | C | 5 | |a 10.1088/0031-9155/58/2/275 |9 -- missing cx lookup -- |1 M Horcicka |p 275 - |2 Crossref |u Horcicka M, Meyer C, Buschbacher A et al (2013) Algorithms for the optimization of RBE-weighted dose in particle therapy. Phys Med Biol 58:275–286 |t Phys Med Biol |v 58 |y 2013 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2008.08.002 |9 -- missing cx lookup -- |1 CA Lawton |p 383 - |2 Crossref |u Lawton CA, Michalski J, El-Naqa I et al (2009) RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 74:383–387 |t Int J Radiat Oncol Biol Phys |v 74 |y 2009 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2012.05.046 |9 -- missing cx lookup -- |1 J Gora |p 881 - |2 Crossref |u Gora J, Stock M, Lutgendorf-Caucig C et al (2013) Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer? Int J Radiat Oncol Biol Phys 85:881–888 |t Int J Radiat Oncol Biol Phys |v 85 |y 2013 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2009.07.1679 |9 -- missing cx lookup -- |1 RC Susil |p 1251 - |2 Crossref |u Susil RC, McNutt TR, DeWeese TL et al (2010) Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys 76:1251–1258 |t Int J Radiat Oncol Biol Phys |v 76 |y 2010 |
| 999 | C | 5 | |a 10.1111/1754-9485.12239 |9 -- missing cx lookup -- |1 Y Choi |p 236 - |2 Crossref |u Choi Y, Kwak DW, Lee HS et al (2015) Effect of rectal enema on intrafraction prostate movement during image-guided radiotherapy. J Med Imaging Radiat Oncol 59:236–242 |t J Med Imaging Radiat Oncol |v 59 |y 2015 |
| 999 | C | 5 | |a 10.1016/j.radonc.2014.05.008 |9 -- missing cx lookup -- |1 KK Wang |p 89 - |2 Crossref |u Wang KK, Vapiwala N, Bui V et al (2014) The impact of stool and gas volume on intrafraction prostate motion in patients undergoing radiotherapy with daily endorectal balloon. Radiother Oncol 112:89–94 |t Radiother Oncol |v 112 |y 2014 |
| 999 | C | 5 | |a 10.1093/jrr/rrt070 |9 -- missing cx lookup -- |1 W Chen |p i82 - |2 Crossref |u Chen W, Gemmel A, Rietzel E (2013) A patient-specific planning target volume used in ‘plan of the day’ adaptation for interfractional motion mitigation. J Radiat Res 54:i82–i90 |t J Radiat Res |v 54 |y 2013 |
| 999 | C | 5 | |a 10.1016/j.radonc.2012.07.003 |9 -- missing cx lookup -- |1 S Lettmaier |p 181 - |2 Crossref |u Lettmaier S, Lotter M, Kreppner S et al (2012) Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer. Radiother Oncol 104:181–186 |t Radiother Oncol |v 104 |y 2012 |
| 999 | C | 5 | |a 10.1007/s00066-013-0373-7 |9 -- missing cx lookup -- |1 G Lahmer |p 668 - |2 Crossref |u Lahmer G, Lotter M, Kreppner S et al (2013) Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy. Strahlenther Onkol 189:668–674 |t Strahlenther Onkol |v 189 |y 2013 |
| 999 | C | 5 | |a 10.1007/s00066-014-0762-6 |9 -- missing cx lookup -- |1 H Badakhshi |p 303 - |2 Crossref |u Badakhshi H, Graf R, Budach V et al (2015) Permanent interstitial low-dose-rate brachytherapy for patients with low risk prostate cancer: an interim analysis of 312 cases. Strahlenther Onkol 191:303–309 |t Strahlenther Onkol |v 191 |y 2015 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2013.11.241 |9 -- missing cx lookup -- |1 D Georg |p 715 - |2 Crossref |u Georg D, Hopfgartner J, Gora J et al (2014) Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys 88:715–722 |t Int J Radiat Oncol Biol Phys |v 88 |y 2014 |
| 999 | C | 5 | |a 10.1118/1.4905374 |9 -- missing cx lookup -- |1 R Grun |p 1037 - |2 Crossref |u Grun R, Friedrich T, Kramer M et al (2015) Assessment of potential advantages of relevant ions for particle therapy: a model based study. Med Phys 42:1037–1047 |t Med Phys |v 42 |y 2015 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|